Reference
Jiao C, et al. Pro-Active 4SCAR2.0 Therapy with NGS-MRD Disease Monitoring in High-Risk B Cell Leukemia Management. Blood 140 (Suppl. 1) : 12744-12745, Nov 2022. Available from: URL: https://dx.doi.org/10.1182/blood-2022-159884 [abstract]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1986, 50 (2023). https://doi.org/10.1007/s40278-023-51355-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-51355-4